Search Within
Document Type
1912-32-9
Keyword:'1912-32-9'
Showing 1-9 of 9 results for "1912-32-9" within Technical Documents
TB026VM pET-3a-d Vector Map
BsaHI 6 691 712 826 1483 4182
4564
BsaJI 9 115 129 435 805 811
1444 1646 1724 2912
BsaWI 6 380 970 1941 2958 3105
3936
BsbI 2 2468 4188
BscGI 1 1912
BsiI 3 2925 4309 4616
BsiEI 7 289 933
TB230 pET-39b Vector Map
509 2366
HphI 21
KpnI 1 271
MaeIII 18
MboII 19
MluI 1 1860
MnlI 26
MseI 29
MslI 6 1912 2200 2230 2948 3143
3534
MspI 32
MspA1I 13
MunI 2 332 534
MwoI 43
NarI 4 1183 1204 1318 2500
NciI 14
NcoI 1 227
NdeI
RonaCare Allantoin
a century, maggots and comfrey
roots have been used with some considerable
success in medicine. In 1912 in England,
Macalister found out that the active ingre-
dient of the comfrey root is allantoin. In
Plant Growth
-3-acetate
1 gI 9770
E
(Indole-3-acetic acid methyl ester; Methyl 3-
indolylacetate)
CAS No. 1912-33-0
C11H11NO2 FW 189.2
suitable (Standard for IAA Immunoassay Kit, PGR-3),
minimum99%
S: 22-24/25
White Paper Monocyte Activation Test
frequently termed “injection fever”. The first fever-
causing agents, “pyrogens”, were identified in 1912 by
Hort and Penfold, who were also the first to design a
pyrogen test based on injection of material
Monocyte Activation Test (MAT) White paper
frequently termed “injection fever”. The first fever-
causing agents, “pyrogens”, were identified in 1912 by
Hort and Penfold, who were also the first to design a
pyrogen test based on injection of material
White Paper: Alternatives to in vivo assays for biosafety testing of biologics
established by Hort and Penfold using the rabbit
model, following the identification of pyrogens in 1912.
At that time, the pyrogenic agent was identified as
endotoxin in preparations of Gram-negative
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
kit 32-046
p38α/SAPK2a KinEASE FP-645nm FarRed Assay KA 1 kit 32-126
p38β2/SAPK2b2 KinEASE FP Fluorescein Green Assay KA 1 kit 32-047
p38β2/SAPK2b2 KinEASE FP-645nm FarRed Assay KA 1 kit 32-127
Acta Interactive Archive Vol 51
h
78%
69%
57%
31 other examples, 32–82%
NH
NO
Me
N
NO
Me
N•
NO
Me
84 mg (0.2 mmol)
2.1 g (5 mmol)
10.1 g (24 mmol)
Scheme